This page includes the latest FDA filings for Iovance Biotherapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | IOVA | DUNS 962508433 |
Device Company | Device | Date |
|---|---|---|
| Iovance Biotherapeutics Inc., Iovance Biotherpeutics Manufacturing, LLC, WuXi Advanced Therapies, Inc. | Other Medication | 2025-09-21 |
| Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-12-22 |
| Iovance Biotherapeutics Inc., Iovance Biotherpeutics Manufacturing, LLC, WuXi Advanced Therapies, Inc. | Other Medication | 2024-10-23 |
| Iovance Biotherapeutics Inc., Iovance Biotherpeutics Manufacturing, LLC, WuXi Advanced Therapies, Inc. | Other Medication | 2024-03-02 |
| Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-02-08 |
| Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-02-07 |
| SEC | 0001425205 | IOVANCE BIOTHERAPEUTICS, INC. of DELAWARE |